Inventor · disambiguated record
David Isenberg
Also filed as: ISENBERG DAVID
0 granted patents·4 pending applications·0 citations·filing 2017–2020
Top patents by PatentIndex Score
4 records- 0158US2020338195A1Pharmaceutical compositions comprising 0.25 mg dose of synthetic human peptides for treating systemic lupus erythematosusXTL BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 0250US2018043016A1Pharmaceutical compositions comprising 0.25 mg dose of synthetic human peptides for treating systemic lupus erythematosusXTL BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 0345US2022396630A1Type i interferon inhibition in systemic lupus erythematosusASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 0444US2018043017A1Pharmaceutical compositions comprising 0.5 mg dose of synthetic human peptides for treating systemic lupus erythematosusXTL BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Isenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →